Novartis | NVS - Ebit





Ebit تغيير تاريخ
AbbVie USD 6.88B 156M 2026-09
Amgen USD 4.61B 777M 2026-06
AstraZeneca USD 4.66B 1.5B 2026-09
Bausch Health Companies USD 993M 217M 2026-09
Biogen USD 419.5M 663.3M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Canopy Growth CAD -2.03M 143.62M 2026-06
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Drreddys Laboratories INR 13.52B 10.47B 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Glaxosmithkline GBP 2.15B 157M 2026-09
J&J USD 6.47B 1B 2026-09
Merck USD 7.33B 6.49B 2026-09
Novartis USD 5.14B 411M 2026-09
Novartis USD 1.78B 2.4B 2026-09
Pacira USD 9.96M 5.33M 2026-06
Perrigo USD 33.6M 50.8M 2026-03
Pfizer USD -180M 5.16B 2026-06
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 52.52M 22.97M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 3.6B 2026-09
Sanofi EUR 1.12B 1.06B 2026-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Zoetis USD 1.12B 279M 2026-06